Neumora Therapeutics, Inc. (NMRA)
0.7031
-0.03
(-3.86%)
USD |
NASDAQ |
Sep 24, 16:00
0.6978
-0.01
(-0.75%)
After-Hours: 19:59
Neumora Therapeutics Total Return Level : 0.7031 for Sept. 24, 2026
Total Return Level Chart
Sep '18
Jan '19
May '19
285.00
270.00
255.00
240.00
Historical Total Return Level Data
| Date | Value |
|---|---|
| September 24, 2026 | 0.7031 |
| September 23, 2026 | 0.7313 |
| September 22, 2026 | 0.7785 |
| September 21, 2026 | 0.6918 |
| September 18, 2026 | 0.73 |
| September 17, 2026 | 0.75 |
| September 16, 2026 | 0.7732 |
| September 15, 2026 | 0.8313 |
| September 14, 2026 | 0.9994 |
| September 11, 2026 | 1.04 |
| September 10, 2026 | 1.14 |
| September 09, 2026 | 1.20 |
| September 08, 2026 | 1.25 |
| September 04, 2026 | 1.31 |
| September 03, 2026 | 1.35 |
| September 02, 2026 | 1.38 |
| September 01, 2026 | 1.33 |
| August 31, 2026 | 1.33 |
| August 28, 2026 | 1.39 |
| August 27, 2026 | 1.48 |
| August 26, 2026 | 1.56 |
| August 25, 2026 | 1.50 |
| August 24, 2026 | 1.525 |
| August 21, 2026 | 1.63 |
| August 20, 2026 | 1.515 |
| Date | Value |
|---|---|
| August 19, 2026 | 1.64 |
| August 18, 2026 | 1.64 |
| August 17, 2026 | 1.52 |
| August 14, 2026 | 1.60 |
| August 13, 2026 | 1.73 |
| August 12, 2026 | 1.71 |
| August 11, 2026 | 1.70 |
| August 10, 2026 | 1.62 |
| August 07, 2026 | 1.63 |
| August 06, 2026 | 1.64 |
| August 05, 2026 | 1.61 |
| August 04, 2026 | 1.60 |
| August 03, 2026 | 1.64 |
| July 31, 2026 | 1.61 |
| July 30, 2026 | 1.65 |
| July 29, 2026 | 1.65 |
| July 28, 2026 | 1.68 |
| July 27, 2026 | 1.66 |
| July 24, 2026 | 1.49 |
| July 23, 2026 | 1.56 |
| July 22, 2026 | 1.54 |
| July 21, 2026 | 1.615 |
| July 20, 2026 | 1.63 |
| July 17, 2026 | 1.61 |
| July 16, 2026 | 1.60 |
Total Return Level Definition
The total return level allows investors to view the performance of a security inclusive of both price appreciation and dividends/distributions. Total return level is seen as the most accurate calculation that produces returns consistent with most other sources.
Total Return Level Range, Past 5 Years
--
Minimum
--
Maximum
--
Average
--
Median
Total Return Level Benchmarks
| BioAge Labs, Inc. | 7.21 |
| LB Pharmaceuticals, Inc. | 37.80 |
| ANI Pharmaceuticals, Inc. | 74.04 |
| Corcept Therapeutics, Inc. | 118.51 |
| Veru, Inc. | 2.934 |